Muscleblind participates in RNA toxicity of expanded CAG and CUG repeats in Caenorhabditis elegans LC Wang, KY Chen, H Pan, CC Wu, PH Chen, YT Liao, C Li, ML Huang, ... Cellular and Molecular Life Sciences 68, 1255-1267, 2011 | 71 | 2011 |
Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals ML Yeh, CF Huang, MH Hsieh, YM Ko, KY Chen, TW Liu, YH Lin, ... Journal of gastroenterology and hepatology 32 (10), 1754-1762, 2017 | 66 | 2017 |
Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells TW Chang, CC Chen, KY Chen, JH Su, JH Chang, MC Chang Oncogene 27 (3), 332-338, 2008 | 61 | 2008 |
Genetics variants and serum levels of MHC class I chain-related A in predicting hepatocellular carcinoma development in chronic hepatitis C patients post antiviral treatment CF Huang, CY Huang, ML Yeh, SC Wang, KY Chen, YM Ko, CC Lin, ... EBioMedicine 15, 81-89, 2017 | 36 | 2017 |
Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9 KY Chen, CC Chen, YC Chang, MC Chang PLoS One 14 (7), e0219317, 2019 | 35 | 2019 |
Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy CF Huang, ML Yeh, CY Huang, PC Tsai, YM Ko, KY Chen, ZY Lin, ... Medicine 95 (27), e4157, 2016 | 34 | 2016 |
Length-dependent toxicity of untranslated CUG repeats on Caenorhabditis elegans KY Chen, H Pan, MJ Lin, YY Li, LC Wang, YC Wu, KM Hsiao Biochemical and biophysical research communications 352 (3), 774-779, 2007 | 34 | 2007 |
Upregulation of RPA2 promotes NF-κB activation in breast cancer by relieving the antagonistic function of menin on NF-κB-regulated transcription CC Chen, CW Juan, KY Chen, YC Chang, JC Lee, MC Chang Carcinogenesis 38 (2), 196-206, 2017 | 25 | 2017 |
Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues TY Jang, YJ Wei, TW Liu, ML Yeh, SF Liu, CT Hsu, PY Hsu, YH Lin, ... Scientific Reports 11 (1), 8184, 2021 | 21 | 2021 |
Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan MY Lu, CT Chen, YL Shih, PC Tsai, MH Hsieh, CF Huang, ML Yeh, ... Scientific reports 11 (1), 8554, 2021 | 19 | 2021 |
Growth-dependent effect of muscleblind knockdown on Caenorhabditis elegans LC Wang, WT Hung, H Pan, KY Chen, YC Wu, YF Liu, KM Hsiao Biochemical and biophysical research communications 366 (3), 705-709, 2008 | 17 | 2008 |
GCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotion K Chen, C Chen, Y Tseng, Y Chang, MC Chang Oncotarget 5 (13), 5017, 2014 | 14 | 2014 |
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison CT Chen, MY Lu, MH Hsieh, PC Tsai, TY Hsieh, ML Yeh, CI Huang, ... World Journal of Gastroenterology 28 (2), 263, 2022 | 13 | 2022 |
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues TY Jang, YJ Wei, ML Yeh, SF Liu, CT Hsu, PY Hsu, TW Liu, YH Lin, ... Journal of the Formosan Medical Association 120 (1), 303-310, 2021 | 11 | 2021 |
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels PY Hsu, TS Cheng, SC Chuang, WT Chang, PC Liang, CT Hsu, YJ Wei, ... Cancer Medicine 11 (1), 104-116, 2022 | 10 | 2022 |
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication MY Lu, ML Yeh, CI Huang, SC Wang, YS Tsai, PC Tsai, YM Ko, CC Lin, ... World Journal of Gastroenterology 28 (1), 140, 2022 | 9 | 2022 |
Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir CF Huang, ML Yeh, CI Huang, PC Liang, YH Lin, MY Hsieh, KY Chen, ... Journal of gastroenterology and hepatology 35 (1), 151-156, 2020 | 9 | 2020 |
Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos (t) ides analogues therapy TY Jang, YJ Wei, CT Hsu, PY Hsu, TW Liu, YH Lin, PC Liang, MH Hsieh, ... Journal of Gastroenterology and Hepatology 35 (11), 1886-1892, 2020 | 8 | 2020 |
Viral interference between dengue virus and Hepatitis C virus infections PC Liang, KY Chen, CH Huang, K Chang, PL Lu, ML Yeh, CF Huang, ... Open Forum Infectious Diseases 7 (8), ofaa272, 2020 | 7 | 2020 |
Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradication MY Lu, TW Liu, PC Liang, CI Huang, YS Tsai, PC Tsai, YM Ko, WH Wang, ... American Journal of Cancer Research 13 (1), 190, 2023 | 6 | 2023 |